RMD Q4 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.2B+9.0% YoY

Gross Profit

$704M57.6% margin

Operating Income

$381M31.2% margin

Net Income

$292M23.9% margin

EPS (Diluted)

$1.98

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

$440M

Free Cash Flow

$414M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$6.9B

Total Liabilities

$2.0B

Stockholders' Equity

$4.9B

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+9.0%
Gross Profit	$704M	$617M	+14.1%
Operating Income	$381M	$275M	+38.5%
Net Income	$292M	$230M	+27.2%

Revenue Segments

Sleep And Respiratory

$1.1B88%

Software As Service

$152M12%